156 related articles for article (PubMed ID: 1973591)
1. Comparison of somatostatin and vasopressin in bleeding esophageal varices.
Saari A; Klvilaakso E; Inberg M; Pääkkönen M; Lahtinen J; Höckerstedt K; Schröder T
Am J Gastroenterol; 1990 Jul; 85(7):804-7. PubMed ID: 1973591
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding.
Planas R; Quer JC; Boix J; Canet J; Armengol M; Cabre E; Pintanel T; Humbert P; Oller B; Broggi MA
Hepatology; 1994 Aug; 20(2):370-5. PubMed ID: 7913907
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial.
Villanueva C; Ortiz J; Sàbat M; Gallego A; Torras X; Soriano G; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
Hepatology; 1999 Aug; 30(2):384-9. PubMed ID: 10421644
[TBL] [Abstract][Full Text] [Related]
4. A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices.
Chojkier M; Groszmann RJ; Atterbury CE; Bar-Meir S; Blei AT; Frankel J; Glickman MG; Kniaz JL; Schade R; Taggart GJ; Conn HO
Gastroenterology; 1979 Sep; 77(3):540-6. PubMed ID: 313353
[TBL] [Abstract][Full Text] [Related]
5. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
Walker S; Kreichgauer HP; Bode JC
Z Gastroenterol; 1996 Oct; 34(10):692-8. PubMed ID: 8921578
[TBL] [Abstract][Full Text] [Related]
6. [Current therapeutic possibilities in esophageal varices].
Sauerbruch T
Praxis (Bern 1994); 1994 Nov; 83(46):1275-6. PubMed ID: 7973289
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological therapy of portal hypertension].
Miotti T; Reichen J
Schweiz Med Wochenschr; 1985 Oct; 115(42):1468-75. PubMed ID: 2866582
[TBL] [Abstract][Full Text] [Related]
8. Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk.
Huizinga WK; Angorn IB; Baker LW
Surg Gynecol Obstet; 1985 Jun; 160(6):539-46. PubMed ID: 3873713
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
[TBL] [Abstract][Full Text] [Related]
10. Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices.
Masci E; Stigliano R; Mariani A; Bertoni G; Baroncini D; Cennamo V; Micheletti G; Casetti T; Tansini P; Buscarini E; Ranzato R; Norberto L
Hepatogastroenterology; 1999; 46(27):1769-73. PubMed ID: 10430341
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic sclerotherapy of oesophageal varices. A clinical study.
Söderlund C
Acta Chir Scand Suppl; 1985; 524():1-86. PubMed ID: 3893006
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial.
Evrard S; Dumonceau JM; Delhaye M; Golstein P; Devière J; Le Moine O
Endoscopy; 2003 Sep; 35(9):729-35. PubMed ID: 12929019
[TBL] [Abstract][Full Text] [Related]
13. Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial.
Morales GF; Pereira Lima JC; Hornos AP; Marques DL; Costa CS; Lima Pereira L; Lopes CV; Raymondi R; Marroni CA
Hepatogastroenterology; 2007; 54(73):195-200. PubMed ID: 17419259
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with somatostatin of variceal digestive hemorrhage: a one-year prospective].
Yuguero del Moral L; López Morante AJ; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1990 Oct; 78(4):201-4. PubMed ID: 1982057
[TBL] [Abstract][Full Text] [Related]
15. Embolization combined with endoscopic variceal ligation for the treatment of esophagogastric variceal bleeding in patients with cirrhosis.
Huang LY; Cui J; Wu CR; Liu YX
Chin Med J (Engl); 2007 Jan; 120(1):36-40. PubMed ID: 17254485
[TBL] [Abstract][Full Text] [Related]
16. [Octreotide in the treatment of acute gastrointestinal hemorrhage caused by ruptured esophageal varices].
Arfaoui D; Elloumi H; Ajmi S
Tunis Med; 2004 Oct; 82(10):947-50. PubMed ID: 15686191
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices.
Vlachogiannakos J; Kougioumtzian A; Triantos C; Viazis N; Sgouros S; Manolakopoulos S; Saveriadis A; Markoglou C; Economopoulos T; Karamanolis DG
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1479-87. PubMed ID: 17919272
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices.
Lo GH; Lai KH; Cheng JS; Chen MH; Chiang HT
Hepatology; 2001 May; 33(5):1060-4. PubMed ID: 11343232
[TBL] [Abstract][Full Text] [Related]
19. [Drug treatment of bleeding esophageal varices. Acute therapy and prevention of recurrence].
Maier KP
Dtsch Med Wochenschr; 1986 Feb; 111(8):306-13. PubMed ID: 2868875
[No Abstract] [Full Text] [Related]
20. VP/NTG therapy in the patient with variceal bleeding.
Burns SM; Martin MJ
Crit Care Nurse; 1990 Oct; 10(9):42-9. PubMed ID: 2121418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
